|Original language||English (US)|
|Pages (from-to)||No. 1157|
|Journal||Proceedings of the American Association for Cancer Research|
|State||Published - Jan 1 1985|
ASJC Scopus subject areas
Paietta, E., & Wiernik, P. H. (1985). Variable reactivity of monoclonal antibodies (MAB) against the X-hapten indicates structural differences in the X-determinant expressed on Hodgkin's (HD) and other cell lines: Effect of neuraminidase treatment (NT). Proceedings of the American Association for Cancer Research, VOL. 26, No. 1157.